HOME >> BIOLOGY >> NEWS
Nanotechnology enables low-dose treatment of atherosclerotic plaques

for early intervention of atherosclerosis, the research group hopes that they can help alleviate the need for more invasive treatment of later-stage atherosclerosis.

"We wanted to go after the early stages of the disease when patients don't yet need immediate intervention to prevent serious cardiac problems," Winter says. "We think fumagillin nanoparticles potentially could be incorporated into a protocol that includes lipid-lowering statin drugs or dietary changes." Next, the research group plans to study the effect of fumagillin nanoparticles in the treatment of cancerous tumors. According to Winter, the use of inhibitors of blood vessel growth is a well-accepted therapy for cancer, suggesting the nanotechnology may prove beneficial in cancer therapy.

Winter PM, Neubauer AM, Caruthers SD, Harris TD, Robertson JD, Williams TA, Schmieder AH, Hu G, Allen JS, Lacy EK, Wickline SA, Lanza GM. Endothelial 3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology September 2006, available on line ahead of print.


'"/>

Contact: Gwen Ericson
ericsong@wustl.edu
314-286-0141
Washington University School of Medicine
27-Jul-2006


Page: 1 2 3

Related biology news :

1. Nanotechnology helps scientists make bendy sensors for hydrogen vehicles
2. FDA Nanotechnology Task Force takes positive step forward
3. Nanotechnology, medicine and bioethics
4. Nanotechnology: consumers must be convinced benefits outweigh risks
5. Nanotechnology requires immediate changes in EPA
6. Nanotechnology provides green path to environmentally sustainable economy
7. Nanotechnology offers hope for treating spinal cord injuries, diabetes and Parkinsons disease
8. Green Nanotechnology: Its Easier Than You Think
9. Nanotechnologys past, present and future: A Congressional perspective
10. Nanotechnology oversight requires thinking outside the box
11. Change in webcast time for Wednesday event on NIOSH Nanotechnology Research Center progress report

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/4/2019)... TORONTO (PRWEB) , ... June 04, 2019 , ... ... automate the search for salient features of seizure risk signals, usually based on ... neurologist-driven EEG interpretation remains the only acceptable diagnostic methodology due to the complexity ...
(Date:6/1/2019)... ... May 31, 2019 , ... ... & Rosati recently invested in BioFactura’s $6M Series B Financing Round. , ... value-added institutional investors who bring significant financial and business resources to bear as ...
(Date:5/31/2019)... ... 30, 2019 , ... Join Julie Peacock, Vice President of ... Wednesday, June 19, 2019 at 1pm EDT where she will demonstrate how role-based ... and contract research organizations (CROs) can improve collaboration, auditing, document tracking and reporting. ...
Breaking Biology News(10 mins):
(Date:5/22/2019)... ... May 22, 2019 , ... Artemis (formerly ... $8 million Series A funding round co-led by Astanor Ventures and ... Development Fund and iSelect Fund . The company has raised $11.75m to ...
(Date:5/15/2019)... ... May 16, 2019 , ... Emulsifiers are the ... and beverage products rely on these ingredients to create stable quality food that ... This paradigm shift triggers food formulators to seek out alternatives for starches, gums ...
(Date:5/8/2019)... , ... May 07, 2019 , ... Standing at 16.2 hands, Atlas is on the ... in a drill team and barrel racing, among other activities. When loping around a ... He went from being a busy horse to only being able to walk. Fortunately ...
(Date:5/4/2019)... , ... May 03, 2019 , ... ... release of the Diopsys® ffERG/Photopic Negative Response vision test, a new ... By 2050, it is estimated that 6.3 million Americans will have glaucoma, with ...
Breaking Biology Technology:
Cached News: